Aytu BioScience to acquire Innovus Pharmaceuticals

Aytu BioScience to acquire Innovus Pharmaceuticals

ENGLEWOOD SAN DIEGO -- Aytu BioScience, Inc . (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, and Innovus... Read More

Friday September 20, 2019 0 comments Tags: Englewood, Aytu BioScience, Innovus Pharma, Josh Disbrow

Aytu BioScience announces study showing more rapid sleep with spray vs. tablet

Aytu BioScience announces study showing more rapid sleep with spray vs. tablet

ENGLEWOOD -- Aytu BioScience, Inc . (NASDAQ:AYTU) announced publication of a clinical study in the journal Pharmacy and Pharmacology, demonstrating that ZolpiMist, Aytu BioSciences lingual... Read More

Tuesday August 13, 2019 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow, ZolpiMist

Aytu BioScience receives market registration for MiOXSYS System in Mexico

Aytu BioScience receives market registration for MiOXSYS System in Mexico

ENGLEWOOD -- Aytu BioScience, Inc . (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced it has... Read More

Friday March 9, 2018 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow, MiOXSYS

Aytu BioScience announces $12M public offering

Aytu BioScience announces $12M public offering

ENGLEWOOD -- Aytu BioScience, Inc . (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced the pricing of... Read More

Friday March 2, 2018 0 comments Tags: Englewood, Aytu BioScience

Aytu: Natesto prescription growth jumps in January

Aytu: Natesto prescription growth jumps in January

ENGLEWOOD -- Aytu BioScience, Inc . (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced prescription growth... Read More

Wednesday February 21, 2018 0 comments Tags: Englewood, Aytu BioScience, Natesto, Josh Disbrow

Aytu BioScience names David Green new CFO

Aytu BioScience names David Green new CFO

ENGLEWOOD -- Aytu BioScience , Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced the... Read More

Monday December 18, 2017 0 comments Tags: Englewood, Aytu BioScience, David Green, Josh Disbrow

Aytu BioScience receives approval for clinical use of MiOXSYS in Australia

Aytu BioScience receives approval for clinical use of MiOXSYS in Australia

ENGLEWOOD -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced the... Read More

Tuesday November 7, 2017 0 comments Tags: Englewood, Aytu BioScience, MiOXSYS, Josh Disbrow

Aytu BioScience announces stock uplisting to NASDAQ Capital Market on Oct. 20

Aytu BioScience announces stock uplisting to NASDAQ Capital Market on Oct. 20

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced its shares of... Read More

Wednesday October 18, 2017 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow